The global Nasal Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Nasal Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nasal Vaccines.

Report Scope

The Nasal Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nasal Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nasal Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Nasal Vaccines Market Report

Report Metric	Details
Report Name	Nasal Vaccines Market
CAGR	5%
Segment by Type	Flu Vaccines COVID-19 Vaccines Other Vaccines
Segment by Application	Adult Children
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sanofi, AstraZeneca, Abbott, GlaxoSmithKline, Serum Institute of India, Bharat Biotech, Antares Pharma, INJEX Pharma GmbH, BioDiem, PharmaJet and Crossject
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nasal Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nasal Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Nasal Vaccines Market report?

Ans: The main players in the Nasal Vaccines Market are Sanofi, AstraZeneca, Abbott, GlaxoSmithKline, Serum Institute of India, Bharat Biotech, Antares Pharma, INJEX Pharma GmbH, BioDiem, PharmaJet and Crossject

What are the Application segmentation covered in the Nasal Vaccines Market report?

Ans: The Applications covered in the Nasal Vaccines Market report are Adult, Children

What are the Type segmentation covered in the Nasal Vaccines Market report?

Ans: The Types covered in the Nasal Vaccines Market report are Flu Vaccines, COVID-19 Vaccines, Other Vaccines

1 Nasal Vaccines Market Overview

1.1 Product Overview and Scope of Nasal Vaccines

1.2 Nasal Vaccines Segment by Type

1.2.1 Global Nasal Vaccines Market Value Comparison by Type (2024-2030)

1.2.2 Flu Vaccines

1.2.3 COVID-19 Vaccines

1.2.4 Other Vaccines

1.3 Nasal Vaccines Segment by Application

1.3.1 Global Nasal Vaccines Market Value by Application: (2024-2030)

1.3.2 Adult

1.3.3 Children

1.4 Global Nasal Vaccines Market Size Estimates and Forecasts

1.4.1 Global Nasal Vaccines Revenue 2019-2030

1.4.2 Global Nasal Vaccines Sales 2019-2030

1.4.3 Global Nasal Vaccines Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Nasal Vaccines Market Competition by Manufacturers

2.1 Global Nasal Vaccines Sales Market Share by Manufacturers (2019-2024)

2.2 Global Nasal Vaccines Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Nasal Vaccines Average Price by Manufacturers (2019-2024)

2.4 Global Nasal Vaccines Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Nasal Vaccines, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Nasal Vaccines, Product Type & Application

2.7 Nasal Vaccines Market Competitive Situation and Trends

2.7.1 Nasal Vaccines Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Nasal Vaccines Players Market Share by Revenue

2.7.3 Global Nasal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Nasal Vaccines Retrospective Market Scenario by Region

3.1 Global Nasal Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Nasal Vaccines Global Nasal Vaccines Sales by Region: 2019-2030

3.2.1 Global Nasal Vaccines Sales by Region: 2019-2024

3.2.2 Global Nasal Vaccines Sales by Region: 2025-2030

3.3 Global Nasal Vaccines Global Nasal Vaccines Revenue by Region: 2019-2030

3.3.1 Global Nasal Vaccines Revenue by Region: 2019-2024

3.3.2 Global Nasal Vaccines Revenue by Region: 2025-2030

3.4 North America Nasal Vaccines Market Facts & Figures by Country

3.4.1 North America Nasal Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Nasal Vaccines Sales by Country (2019-2030)

3.4.3 North America Nasal Vaccines Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Nasal Vaccines Market Facts & Figures by Country

3.5.1 Europe Nasal Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Nasal Vaccines Sales by Country (2019-2030)

3.5.3 Europe Nasal Vaccines Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Nasal Vaccines Market Facts & Figures by Country

3.6.1 Asia Pacific Nasal Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Nasal Vaccines Sales by Country (2019-2030)

3.6.3 Asia Pacific Nasal Vaccines Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Nasal Vaccines Market Facts & Figures by Country

3.7.1 Latin America Nasal Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Nasal Vaccines Sales by Country (2019-2030)

3.7.3 Latin America Nasal Vaccines Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Nasal Vaccines Market Facts & Figures by Country

3.8.1 Middle East and Africa Nasal Vaccines Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Nasal Vaccines Sales by Country (2019-2030)

3.8.3 Middle East and Africa Nasal Vaccines Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Nasal Vaccines Sales by Type (2019-2030)

4.1.1 Global Nasal Vaccines Sales by Type (2019-2024)

4.1.2 Global Nasal Vaccines Sales by Type (2025-2030)

4.1.3 Global Nasal Vaccines Sales Market Share by Type (2019-2030)

4.2 Global Nasal Vaccines Revenue by Type (2019-2030)

4.2.1 Global Nasal Vaccines Revenue by Type (2019-2024)

4.2.2 Global Nasal Vaccines Revenue by Type (2025-2030)

4.2.3 Global Nasal Vaccines Revenue Market Share by Type (2019-2030)

4.3 Global Nasal Vaccines Price by Type (2019-2030)

5 Segment by Application

5.1 Global Nasal Vaccines Sales by Application (2019-2030)

5.1.1 Global Nasal Vaccines Sales by Application (2019-2024)

5.1.2 Global Nasal Vaccines Sales by Application (2025-2030)

5.1.3 Global Nasal Vaccines Sales Market Share by Application (2019-2030)

5.2 Global Nasal Vaccines Revenue by Application (2019-2030)

5.2.1 Global Nasal Vaccines Revenue by Application (2019-2024)

5.2.2 Global Nasal Vaccines Revenue by Application (2025-2030)

5.2.3 Global Nasal Vaccines Revenue Market Share by Application (2019-2030)

5.3 Global Nasal Vaccines Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Sanofi

6.1.1 Sanofi Corporation Information

6.1.2 Sanofi Description and Business Overview

6.1.3 Sanofi Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Sanofi Nasal Vaccines Product Portfolio

6.1.5 Sanofi Recent Developments/Updates

6.2 AstraZeneca

6.2.1 AstraZeneca Corporation Information

6.2.2 AstraZeneca Description and Business Overview

6.2.3 AstraZeneca Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.2.4 AstraZeneca Nasal Vaccines Product Portfolio

6.2.5 AstraZeneca Recent Developments/Updates

6.3 Abbott

6.3.1 Abbott Corporation Information

6.3.2 Abbott Description and Business Overview

6.3.3 Abbott Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Abbott Nasal Vaccines Product Portfolio

6.3.5 Abbott Recent Developments/Updates

6.4 GlaxoSmithKline

6.4.1 GlaxoSmithKline Corporation Information

6.4.2 GlaxoSmithKline Description and Business Overview

6.4.3 GlaxoSmithKline Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 GlaxoSmithKline Nasal Vaccines Product Portfolio

6.4.5 GlaxoSmithKline Recent Developments/Updates

6.5 Serum Institute of India

6.5.1 Serum Institute of India Corporation Information

6.5.2 Serum Institute of India Description and Business Overview

6.5.3 Serum Institute of India Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Serum Institute of India Nasal Vaccines Product Portfolio

6.5.5 Serum Institute of India Recent Developments/Updates

6.6 Bharat Biotech

6.6.1 Bharat Biotech Corporation Information

6.6.2 Bharat Biotech Description and Business Overview

6.6.3 Bharat Biotech Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Bharat Biotech Nasal Vaccines Product Portfolio

6.6.5 Bharat Biotech Recent Developments/Updates

6.7 Antares Pharma

6.6.1 Antares Pharma Corporation Information

6.6.2 Antares Pharma Description and Business Overview

6.6.3 Antares Pharma Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Antares Pharma Nasal Vaccines Product Portfolio

6.7.5 Antares Pharma Recent Developments/Updates

6.8 INJEX Pharma GmbH

6.8.1 INJEX Pharma GmbH Corporation Information

6.8.2 INJEX Pharma GmbH Description and Business Overview

6.8.3 INJEX Pharma GmbH Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.8.4 INJEX Pharma GmbH Nasal Vaccines Product Portfolio

6.8.5 INJEX Pharma GmbH Recent Developments/Updates

6.9 BioDiem

6.9.1 BioDiem Corporation Information

6.9.2 BioDiem Description and Business Overview

6.9.3 BioDiem Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.9.4 BioDiem Nasal Vaccines Product Portfolio

6.9.5 BioDiem Recent Developments/Updates

6.10 PharmaJet and Crossject

6.10.1 PharmaJet and Crossject Corporation Information

6.10.2 PharmaJet and Crossject Description and Business Overview

6.10.3 PharmaJet and Crossject Nasal Vaccines Sales, Revenue and Gross Margin (2019-2024)

6.10.4 PharmaJet and Crossject Nasal Vaccines Product Portfolio

6.10.5 PharmaJet and Crossject Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Nasal Vaccines Industry Chain Analysis

7.2 Nasal Vaccines Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Nasal Vaccines Production Mode & Process

7.4 Nasal Vaccines Sales and Marketing

7.4.1 Nasal Vaccines Sales Channels

7.4.2 Nasal Vaccines Distributors

7.5 Nasal Vaccines Customers

8 Nasal Vaccines Market Dynamics

8.1 Nasal Vaccines Industry Trends

8.2 Nasal Vaccines Market Drivers

8.3 Nasal Vaccines Market Challenges

8.4 Nasal Vaccines Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

Abbott

Serum Institute of India

PharmaJet and Crossject

List of Tables

Table 1. Global Nasal Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Nasal Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Nasal Vaccines Market Competitive Situation by Manufacturers in 2023

Table 4. Global Nasal Vaccines Sales (K Dose) of Key Manufacturers (2019-2024)

Table 5. Global Nasal Vaccines Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Nasal Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Nasal Vaccines Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Nasal Vaccines Average Price (US$/Dose) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Nasal Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Nasal Vaccines, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Nasal Vaccines, Product Type & Application

Table 12. Global Key Manufacturers of Nasal Vaccines, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Nasal Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nasal Vaccines as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Nasal Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Nasal Vaccines Sales by Region (2019-2024) & (K Dose)

Table 18. Global Nasal Vaccines Sales Market Share by Region (2019-2024)

Table 19. Global Nasal Vaccines Sales by Region (2025-2030) & (K Dose)

Table 20. Global Nasal Vaccines Sales Market Share by Region (2025-2030)

Table 21. Global Nasal Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Nasal Vaccines Revenue Market Share by Region (2019-2024)

Table 23. Global Nasal Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Nasal Vaccines Revenue Market Share by Region (2025-2030)

Table 25. North America Nasal Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Nasal Vaccines Sales by Country (2019-2024) & (K Dose)

Table 27. North America Nasal Vaccines Sales by Country (2025-2030) & (K Dose)

Table 28. North America Nasal Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Nasal Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Nasal Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Nasal Vaccines Sales by Country (2019-2024) & (K Dose)

Table 32. Europe Nasal Vaccines Sales by Country (2025-2030) & (K Dose)

Table 33. Europe Nasal Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Nasal Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Nasal Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Nasal Vaccines Sales by Region (2019-2024) & (K Dose)

Table 37. Asia Pacific Nasal Vaccines Sales by Region (2025-2030) & (K Dose)

Table 38. Asia Pacific Nasal Vaccines Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Nasal Vaccines Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Nasal Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Nasal Vaccines Sales by Country (2019-2024) & (K Dose)

Table 42. Latin America Nasal Vaccines Sales by Country (2025-2030) & (K Dose)

Table 43. Latin America Nasal Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Nasal Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Nasal Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Nasal Vaccines Sales by Country (2019-2024) & (K Dose)

Table 47. Middle East & Africa Nasal Vaccines Sales by Country (2025-2030) & (K Dose)

Table 48. Middle East & Africa Nasal Vaccines Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Nasal Vaccines Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Nasal Vaccines Sales (K Dose) by Type (2019-2024)

Table 51. Global Nasal Vaccines Sales (K Dose) by Type (2025-2030)

Table 52. Global Nasal Vaccines Sales Market Share by Type (2019-2024)

Table 53. Global Nasal Vaccines Sales Market Share by Type (2025-2030)

Table 54. Global Nasal Vaccines Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Nasal Vaccines Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Nasal Vaccines Revenue Market Share by Type (2019-2024)

Table 57. Global Nasal Vaccines Revenue Market Share by Type (2025-2030)

Table 58. Global Nasal Vaccines Price (US$/Dose) by Type (2019-2024)

Table 59. Global Nasal Vaccines Price (US$/Dose) by Type (2025-2030)

Table 60. Global Nasal Vaccines Sales (K Dose) by Application (2019-2024)

Table 61. Global Nasal Vaccines Sales (K Dose) by Application (2025-2030)

Table 62. Global Nasal Vaccines Sales Market Share by Application (2019-2024)

Table 63. Global Nasal Vaccines Sales Market Share by Application (2025-2030)

Table 64. Global Nasal Vaccines Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Nasal Vaccines Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Nasal Vaccines Revenue Market Share by Application (2019-2024)

Table 67. Global Nasal Vaccines Revenue Market Share by Application (2025-2030)

Table 68. Global Nasal Vaccines Price (US$/Dose) by Application (2019-2024)

Table 69. Global Nasal Vaccines Price (US$/Dose) by Application (2025-2030)

Table 70. Sanofi Corporation Information

Table 71. Sanofi Description and Business Overview

Table 72. Sanofi Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 73. Sanofi Nasal Vaccines Product

Table 74. Sanofi Recent Developments/Updates

Table 75. AstraZeneca Corporation Information

Table 76. AstraZeneca Description and Business Overview

Table 77. AstraZeneca Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 78. AstraZeneca Nasal Vaccines Product

Table 79. AstraZeneca Recent Developments/Updates

Table 80. Abbott Corporation Information

Table 81. Abbott Description and Business Overview

Table 82. Abbott Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 83. Abbott Nasal Vaccines Product

Table 84. Abbott Recent Developments/Updates

Table 85. GlaxoSmithKline Corporation Information

Table 86. GlaxoSmithKline Description and Business Overview

Table 87. GlaxoSmithKline Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 88. GlaxoSmithKline Nasal Vaccines Product

Table 89. GlaxoSmithKline Recent Developments/Updates

Table 90. Serum Institute of India Corporation Information

Table 91. Serum Institute of India Description and Business Overview

Table 92. Serum Institute of India Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 93. Serum Institute of India Nasal Vaccines Product

Table 94. Serum Institute of India Recent Developments/Updates

Table 95. Bharat Biotech Corporation Information

Table 96. Bharat Biotech Description and Business Overview

Table 97. Bharat Biotech Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 98. Bharat Biotech Nasal Vaccines Product

Table 99. Bharat Biotech Recent Developments/Updates

Table 100. Antares Pharma Corporation Information

Table 101. Antares Pharma Description and Business Overview

Table 102. Antares Pharma Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 103. Antares Pharma Nasal Vaccines Product

Table 104. Antares Pharma Recent Developments/Updates

Table 105. INJEX Pharma GmbH Corporation Information

Table 106. INJEX Pharma GmbH Description and Business Overview

Table 107. INJEX Pharma GmbH Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 108. INJEX Pharma GmbH Nasal Vaccines Product

Table 109. INJEX Pharma GmbH Recent Developments/Updates

Table 110. BioDiem Corporation Information

Table 111. BioDiem Description and Business Overview

Table 112. BioDiem Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 113. BioDiem Nasal Vaccines Product

Table 114. BioDiem Recent Developments/Updates

Table 115. PharmaJet and Crossject Corporation Information

Table 116. PharmaJet and Crossject Description and Business Overview

Table 117. PharmaJet and Crossject Nasal Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 118. PharmaJet and Crossject Nasal Vaccines Product

Table 119. PharmaJet and Crossject Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Nasal Vaccines Distributors List

Table 123. Nasal Vaccines Customers List

Table 124. Nasal Vaccines Market Trends

Table 125. Nasal Vaccines Market Drivers

Table 126. Nasal Vaccines Market Challenges

Table 127. Nasal Vaccines Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Nasal Vaccines

Figure 2. Global Nasal Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Nasal Vaccines Market Share by Type in 2023 & 2030

Figure 4. Flu Vaccines Product Picture

Figure 5. COVID-19 Vaccines Product Picture

Figure 6. Other Vaccines Product Picture

Figure 7. Global Nasal Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Nasal Vaccines Market Share by Application in 2023 & 2030

Figure 9. Adult

Figure 10. Children

Figure 11. Global Nasal Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Nasal Vaccines Market Size (2019-2030) & (US$ Million)

Figure 13. Global Nasal Vaccines Sales (2019-2030) & (K Dose)

Figure 14. Global Nasal Vaccines Average Price (US$/Dose) & (2019-2030)

Figure 15. Nasal Vaccines Report Years Considered

Figure 16. Nasal Vaccines Sales Share by Manufacturers in 2023

Figure 17. Global Nasal Vaccines Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Nasal Vaccines Players: Market Share by Revenue in 2023

Figure 19. Nasal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Nasal Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Nasal Vaccines Sales Market Share by Country (2019-2030)

Figure 22. North America Nasal Vaccines Revenue Market Share by Country (2019-2030)

Figure 23. United States Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Nasal Vaccines Sales Market Share by Country (2019-2030)

Figure 26. Europe Nasal Vaccines Revenue Market Share by Country (2019-2030)

Figure 27. Germany Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Nasal Vaccines Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Nasal Vaccines Revenue Market Share by Region (2019-2030)

Figure 34. China Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Indonesia Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Thailand Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Malaysia Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America Nasal Vaccines Sales Market Share by Country (2019-2030)

Figure 44. Latin America Nasal Vaccines Revenue Market Share by Country (2019-2030)

Figure 45. Mexico Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Brazil Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Argentina Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Colombia Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Nasal Vaccines Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Nasal Vaccines Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. UAE Nasal Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Nasal Vaccines by Type (2019-2030)

Figure 55. Global Revenue Market Share of Nasal Vaccines by Type (2019-2030)

Figure 56. Global Nasal Vaccines Price (US$/Dose) by Type (2019-2030)

Figure 57. Global Sales Market Share of Nasal Vaccines by Application (2019-2030)

Figure 58. Global Revenue Market Share of Nasal Vaccines by Application (2019-2030)

Figure 59. Global Nasal Vaccines Price (US$/Dose) by Application (2019-2030)

Figure 60. Nasal Vaccines Value Chain

Figure 61. Nasal Vaccines Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions